J-Star Holding Co., Ltd (NASDAQ:YMAT) Sees Significant Increase in Short Interest

J-Star Holding Co., Ltd (NASDAQ:YMAT – Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totaling 65,449 shares, an increase of 237.5% from the August 31st total of 19,393 shares. Based on an average daily trading volume, of 3,670,029 shares, the short-interest ratio is presently 0.0 days. Approximately 2.0% of the shares of the stock are short sold.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Weiss Ratings lowered shares of J-Star from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 9th. Wall Street Zen upgraded shares of J-Star to a “hold” rating in a research report on Saturday, June 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Check Out Our Latest Analysis on YMAT

J-Star Price Performance

Shares of NASDAQ YMAT opened at $1.56 on Friday. J-Star has a 1-year low of $0.85 and a 1-year high of $13.00. The stock’s 50-day moving average is $1.83 and its 200 day moving average is $2.38.

About J-Star

(Get Free Report)

J-Star Holding Co, Ltd. is a pharmaceutical research and development services company that supports pharmaceutical and biotechnology businesses throughout the drug-development process. Through its operating subsidiaries, the company provides contract development services designed to help clients advance drug candidates from early development through clinical manufacturing.

J-Star’s services include preformulation studies, formulation development, analytical method development and validation, stability testing, and the production of clinical trial materials.

Featured Stories

Receive News & Ratings for J-Star Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for J-Star and related companies with MarketBeat.com's FREE daily email newsletter.